Browse Research Interests
 | | |
|---|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| Dr Barbara Cameron
School of Medical Sciences - Department of Pathology | |
| Dr Barrie Gatus
School of Medical Sciences - Department of PathologyStatement of Interests:
Detection of antimicrobial resistance is a prerequisite for the treatment of infections. Collaborative work undertaken with the Institute Pasteur, Paris is focussed on the development of laboratory methods to detect new mechanisms of evolving antimicrobial resistance.
More...
| |
| Professor Andrew Lloyd
School of Medical Sciences - Department of PathologyStatement of Interests:
The goal of the research groups which are led by Professor Lloyd is to understand the cellular and molecular basis of inflammatory processes in human infectious diseases. In particular, Professor Lloyd's research groups are seeking to define the role of cytokines, notably the chemoattractant cytokines (chemokines) in regulation of lymphocyte trafficking. The groups are focussed on studies of the pathogenesis of hepatitis C infection, and the characteristics of the host response to other infections includi ng Epstein-Barr virus, Ross River virus and Coxiella burnetii - the causative agent of Q fever. The scope of the research extends from laboratory studies of the basic biology of genes relevant to disease pathogenesis through to clinical and epidemiological studies in humans. The research includes cellular and molecular immunology techniques, and includes in vitro as well as in vivo studies in animal models of disease
More...
| |
| Associate Professor John Tapsall
School of Medical Sciences - Department of PathologyStatement of Interests:
My research focus is on laboratory contributions for control of diseases of public health importance, with special emphasis on diseases caused by the ptahogenic Neisseria and antimicrobial resistance (AMR). These interests intersect most obviously in gonococcal (GC) disease. Achievements include the formation of the Australian Gonococcal Surveillance Program (AGSP) in 1979 and in 1994 its meningococcal (MC) equivalent (AMSP), now combined and maintained as the National Neisseria Network (NNN) which I co-ordinate. This successful model was used to establish a similar WHO Gonococcal Antimicrobial Surveillance Program (GASP) in its (separate) Western Pacific and South East Asian regions with more than 20 countries participating. These networks provide information for action via annual or quarterly data and analytical reports. N. gonorrhoeae is the most problematic STI in terms of AMR in Australia and globally. Other related outcomes nationally and internationally include optimised laboratory diagnostic procedures (including molecular diagnostics) and formulation of national diagnostic guidelines; applications of pathogen typing methods; and optimisation of programmatic treatments for disease control. Antimicrobial resistance [AMR] is increasing and this decreases treatment options. Surveillance of AMR is needed to determine programmatic as well as individual treatments but must be properly conducted to provide valid data. We conduct, in conjunction with the World Health Organization, comprehensive continuous and active surveillance of AMR in the pathogenc Neisseria (gonococci and meningococci) and link this to disease surveillance and control in Australia and the Western Pacific.
More...
| |
| Dr Peter Taylor
School of Medical Sciences - Department of PathologyStatement of Interests:
Working in the field of diagnostic clinical microbiology there is a need to integrate new techniques and laboratory approaches to clinical testing. Improved and alternate methodology for existing tests and quality improvement are essential components to maintain credibility of diagnostic laboartories.
More...
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |